Peptide length determines the outcome of TCR/peptide-MHCI engagement
Open Access
- 14 February 2013
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 121 (7), 1112-1123
- https://doi.org/10.1182/blood-2012-06-437202
Abstract
αβ-TCRs expressed at the CD8+ T-cell surface interact with short peptide fragments (p) bound to MHC class I molecules (pMHCI). The TCR/pMHCI interaction is pivotal in all aspects of CD8+ T-cell immunity. However, the rules that govern the outcome of TCR/pMHCI engagement are not entirely understood, and this is a major barrier to understanding the requirements for both effective immunity and vaccination. In the present study, we discovered an unexpected feature of the TCR/pMHCI interaction by showing that any given TCR exhibits an explicit preference for a single MHCI-peptide length. Agonists of nonpreferred length were extremely rare, suboptimal, and often entirely distinct in sequence. Structural analysis indicated that alterations in peptide length have a major impact on antigenic complexity, to which individual TCRs are unable to adapt. This novel finding demonstrates that the outcome of TCR/pMHCI engagement is determined by peptide length in addition to the sequence identity of the MHCI-bound peptide. Accordingly, the effective recognition of pMHCI Ag, which is a prerequisite for successful CD8+ T-cell immunity and protective vaccination, can only be achieved by length-matched Ag-specific CD8+ T-cell clonotypes.This publication has 50 references indexed in Scilit:
- T cell receptor recognition of self and foreign antigens in the induction of autoimmunitySeminars in Immunology, 2011
- Modification of MHC Anchor Residues Generates Heteroclitic Peptides That Alter TCR Binding and T Cell RecognitionThe Journal of Immunology, 2010
- Allelic polymorphism in the T cell receptor and its impact on immune responsesThe Journal of Experimental Medicine, 2010
- T Cell Allorecognition via Molecular MimicryImmunity, 2009
- Tricks with tetramers: how to get the most from multimeric peptide–MHCImmunology, 2009
- Have we cut ourselves too short in mapping CTL epitopes?Trends in Immunology, 2006
- T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I–bound peptideNature Immunology, 2005
- Potent T cell response to a class I‐binding 13‐mer viral epitope and the influence of HLA micropolymorphism in controlling epitope lengthEuropean Journal of Immunology, 2004
- TCR Binding to Peptide-MHC Stabilizes a Flexible Recognition InterfaceImmunity, 1999
- Peripheral T Cell Survival Requires Continual Ligation of the T Cell Receptor to Major Histocompatibility Complex–Encoded MoleculesThe Journal of Experimental Medicine, 1997